Dual GLP-1 and Gcg RAs offer a promising approach for managing obesity andpromoting weight loss by combining the appetite-suppressing effects of GLP-1 RAswith the metabolism-enhancing properties of Gcg. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.